Demonstrating the value of early economic evaluation alongside clinical trials: Exercise medicine for men with metastatic prostate cancer

被引:4
|
作者
Edmunds, Kim [1 ,2 ]
Scuffham, Paul [1 ,2 ]
Reeves, Penny [3 ,4 ]
Galvao, Daniel A. [5 ,6 ]
Taaffe, Dennis R. [5 ,6 ]
Newton, Robert U. [5 ,6 ]
Spry, Nigel [5 ,7 ]
Joseph, David [5 ,7 ]
Tuffaha, Haitham [8 ]
机构
[1] Griffith Univ, Ctr Appl Hlth Econ, Brisbane, Qld, Australia
[2] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia
[3] Hunter Med Res Inst, New Lambton Hts, NSW, Australia
[4] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW, Australia
[5] Edith Cowan Univ, Exercise Med Res Inst, Joondalup, WA, Australia
[6] Edith Cowan Univ, Sch Med & Hlth Sci, Joondalup, WA, Australia
[7] Sir Charles Gairdner Hosp, Dept Radiat Oncol, Nedlands, WA, Australia
[8] Univ Queensland, Ctr Business & Econ Hlth, Brisbane, Qld, Australia
关键词
cost-effectiveness analysis; economic evaluation; exercise medicine; metastatic prostate cancer; value of information analysis;
D O I
10.1111/ecc.13479
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Evaluation and Effectiveness of Clinical Trials with Hormone Therapy in the Treatment of Prostate Cancer
    Ramos-Barriga, Olga
    Padilla-Fernandez, Barbara-Yolanda
    Valverde-Martinez, Sebastian
    Peran-Teruel, Miguel
    Marquez-Sanchez, Magaly-Teresa
    Flores-Fraile, Maria-Carmen
    Flores-Fraile, Javier
    Martin-Hernandez, Mario
    Grinard-de-Leon, Edwin
    Garcia-Cenador, Maria-Begona
    Lorenzo-Gomez, Maria-Fernanda
    APPLIED SCIENCES-BASEL, 2022, 12 (10):
  • [42] ECONOMIC EVALUATION OF PERCENT FREE PSA FOR PROSTATE CANCER DETECTION IN TAIWANESE MEN
    Lai, A. Y. H.
    VALUE IN HEALTH, 2014, 17 (07) : A469 - A469
  • [43] Elevating the Patient Voice in Metastatic Hormone-Sensitive Prostate Cancer Clinical Trials
    Dzimitrowicz, Hannah E.
    Armstrong, Andrew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (08) : 807 - +
  • [44] Clinical trials in metastatic prostate cancer - Has there been real progress in the past decade?
    Bhandari, MS
    Petrylak, DP
    Hussain, M
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (06) : 941 - 953
  • [45] The Economic Burden of Skeletal-Related Events Among Elderly Men with Metastatic Prostate Cancer
    Jayasekera, J.
    Onukwugha, E.
    Bikov, K.
    Mullins, C. D.
    Seal, B.
    Hussain, A.
    PHARMACOECONOMICS, 2014, 32 (02) : 173 - 191
  • [46] The Economic Burden of Skeletal-Related Events Among Elderly Men with Metastatic Prostate Cancer
    J. Jayasekera
    E. Onukwugha
    K. Bikov
    C. D. Mullins
    B. Seal
    A. Hussain
    PharmacoEconomics, 2014, 32 : 173 - 191
  • [47] Clinical evaluation and treatment in men with low testosterone levels and prostate cancer
    Ljubetic, B. M.
    Parada, F.
    Flores, J. M.
    ACTAS UROLOGICAS ESPANOLAS, 2024, 48 (06): : 410 - 415
  • [48] Prognostic value of comorbidity measures among Australian men with non-metastatic prostate cancer
    Tiruye, Tenaw
    Roder, David
    FitzGerald, Liesel M.
    O'Callaghan, Michael
    Moretti, Kim
    Beckmann, Kerri
    CANCER EPIDEMIOLOGY, 2023, 87
  • [49] Emerging agents for metastatic pancreatic cancer: spotlight on early phase clinical trials
    Kang, Byung Woog
    Chau, Ian
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2021, 30 (11) : 1089 - 1107
  • [50] DISTINCT CLINICAL GENOMIC VARIATIONS AMONG MEN WITH LOCALIZED VS METASTATIC PROSTATE CANCER
    El-shafie, Ahmed
    Al-Toubat, Mohammed
    Feibus, Allison H.
    Jazayeri, SeyedBehzad
    Bazargani, Soroush
    Thomas, Devon
    Bandyk, Mark
    Balaji, K. C.
    JOURNAL OF UROLOGY, 2023, 209 : E330 - E331